CA Stock MarketDetailed Quotes
MYND MYND Life Sciences Inc
- 0.040
- 0.0000.00%
15min DelayMarket Closed Jul 5 11:19 ET
1.91MMarket Cap-2000P/E (TTM)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.10052wk High0.00%Turnover Ratio47.82MShares0.00552wk Low-0.02EPS TTM1.33MFloat Cap2.500Historical HighLossP/E (Static)33.24MShs Float0.005Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-0.36P/B1Lot Size--Div YieldTTM
MYND Life Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | (Q2)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --1 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0.00%60K | 33.33%240K | 0.00%60K | -50.00%60K | 60K | 60K | 180K | 60K | 120K | 0 |
| Gross profit | 0.00%-60K | -33.33%-240K | 0.00%-60K | 50.00%-60K | -60K | -60K | -180K | -30.61%-60K | -361.22%-120K | 0 |
| Operating expense | -53.14%274.43K | -44.90%1.59M | -26.70%328.55K | -54.78%254.44K | -41.42%420.13K | -49.63%585.65K | -32.82%2.88M | -69.09%448.19K | -37.43%562.65K | -5.93%717.23K |
| Selling and administrative expenses | -74.94%112.12K | -21.76%1.19M | 32.21%123.8K | -14.50%213.44K | 20.47%400.55K | -47.15%447.32K | -50.68%1.51M | -88.75%93.64K | -65.59%249.64K | -47.17%332.48K |
| -Selling and marketing expense | -99.20%2.52K | 165.91%362.07K | -53.83%12.07K | -51.59%10.6K | -45.98%24.4K | 633.22%315K | -66.75%136.16K | -93.62%26.14K | --21.9K | --45.16K |
| -General and administrative expense | -17.16%109.61K | -40.29%823.05K | 65.52%111.74K | -10.93%202.84K | 30.92%376.16K | -83.53%132.32K | -48.21%1.38M | -84.04%67.51K | -68.61%227.73K | -54.35%287.31K |
| Research and development costs | 51.23%151.23K | -76.13%282.28K | -39.24%182.28K | --0 | --0 | -64.02%100K | 9.60%1.18M | -47.68%300K | 106.85%285.63K | 214.09%318.97K |
| Depreciation amortization depletion | -94.24%653 | -64.92%20.99K | -92.33%892 | -92.34%891 | -47.46%7.86K | -47.53%11.34K | -30.53%59.83K | -61.17%11.63K | -47.05%11.63K | -26.84%14.96K |
| -Depreciation and amortization | -94.24%653 | -64.92%20.99K | -92.33%892 | -92.34%891 | -47.46%7.86K | -47.53%11.34K | -30.53%59.83K | -61.17%11.63K | -47.05%11.63K | -26.84%14.96K |
| Other operating expenses | -61.34%10.43K | -20.49%100.39K | -49.74%21.57K | 154.51%40.11K | -76.94%11.72K | 61.18%26.98K | 128.89%126.26K | 202.14%42.93K | 14.52%15.76K | 358.86%50.83K |
| Operating profit | 48.20%-334.43K | 40.30%-1.83M | 23.54%-388.55K | 53.94%-314.44K | 33.06%-480.13K | 44.47%-645.65K | 28.62%-3.06M | 66.03%-508.19K | 20.00%-682.65K | 5.93%-717.23K |
| Net non-operating interest income (expenses) | 80.13%-38.33K | -10.39%-731.76K | 31.21%-124.26K | -27.85%-216.36K | -26.75%-198.24K | -23.15%-192.9K | -391.47%-662.91K | -93.24%-180.64K | -1,017.78%-169.22K | -890.63%-156.4K |
| Non-operating interest expense | -80.13%38.33K | 10.39%731.76K | -31.21%124.26K | 27.85%216.36K | 26.75%198.24K | 23.15%192.9K | 391.47%662.91K | 93.24%180.64K | 1,017.78%169.22K | 890.63%156.4K |
| Other net income (expenses) | 3,504.20%1.04M | 16,274.97%981.84K | 21 | 316.45%60.75K | -99.44%47 | 126.53%28.93K | 6K | 14.59K | ||
| Special income (charges) | ---- | 6,768.96%999.3K | --981.84K | --0 | 19.98%17.45K | ---- | 113.34%14.55K | --0 | --0 | --14.55K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | -19.98%-17.45K | ---- | ---14.55K | --0 | ---- | ---14.55K |
| -Gain on sale of business | ---- | --999.3K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | 201.52%43.36K | -99.98%1 | --21 | 110,907.69%43.29K | -99.44%47 | --14.38K | --6K | ---- | --39 |
| Income before tax | 55.54%-372.76K | 58.95%-1.52M | 168.69%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.48%-3.7M | 59.79%-682.84K | 1.91%-851.87K | -10.39%-859.05K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 22.79%-129.95K | 17.90%-129.95K | 0 | 0 | |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 64.10%-552.89K | 0.77%-851.87K | -11.83%-859.05K |
| Net income continuous operations | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 64.10%-552.89K | 0.77%-851.87K | -11.83%-859.05K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 84.60%-552.89K | 0.77%-851.87K | -11.83%-859.05K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 55.54%-372.76K | 57.45%-1.52M | 184.83%469.04K | 37.69%-530.78K | 28.10%-617.62K | 36.04%-838.5K | 18.32%-3.57M | 84.60%-552.89K | 0.77%-851.87K | -11.83%-859.05K |
| Diluted earnings per share | 50.00%-0.01 | 62.50%-0.03 | 150.00%0.01 | 50.00%-0.01 | 50.00%-0.01 | 33.33%-0.02 | 20.00%-0.08 | 50.00%-0.02 | 0.00%-0.02 | -19.59%-0.02 |
| Basic earnings per share | 50.00%-0.01 | 62.50%-0.03 | 150.00%0.01 | 50.00%-0.01 | 50.00%-0.01 | 33.33%-0.02 | 20.00%-0.08 | 50.00%-0.02 | 0.00%-0.02 | -19.59%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg